Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

Clinical trial NCT05196828 · COMPLETED

Trial details

NCT number: NCT05196828
Sponsor: Noctrix Health, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Restless Legs Syndrome

Start date: 2021-12-20
Primary completion: 2022-09-27
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.